MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 1 filers reported holding MOMENTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,276,000 | +54.1% | 81,481 | -2.3% | 0.02% | +53.8% |
| Q2 2020 | $2,774,000 | +30.7% | 83,368 | +6.8% | 0.01% | +8.3% |
| Q1 2020 | $2,123,000 | +48.3% | 78,040 | +7.5% | 0.01% | +100.0% |
| Q4 2019 | $1,432,000 | +51.2% | 72,578 | -0.7% | 0.01% | +50.0% |
| Q3 2019 | $947,000 | +2.9% | 73,072 | -1.1% | 0.00% | 0.0% |
| Q2 2019 | $920,000 | -14.1% | 73,880 | +0.2% | 0.00% | 0.0% |
| Q1 2019 | $1,071,000 | +55.4% | 73,710 | +18.0% | 0.00% | +33.3% |
| Q4 2018 | $689,000 | -56.7% | 62,451 | +3.3% | 0.00% | -40.0% |
| Q3 2018 | $1,590,000 | +31.3% | 60,448 | +2.1% | 0.01% | +25.0% |
| Q2 2018 | $1,211,000 | +38.1% | 59,221 | +22.5% | 0.00% | +33.3% |
| Q1 2018 | $877,000 | +4.4% | 48,329 | -19.7% | 0.00% | 0.0% |
| Q4 2017 | $840,000 | -22.4% | 60,202 | +2.9% | 0.00% | -25.0% |
| Q3 2017 | $1,082,000 | +18.3% | 58,491 | +8.0% | 0.00% | +33.3% |
| Q2 2017 | $915,000 | +71.3% | 54,134 | +35.3% | 0.00% | +50.0% |
| Q1 2017 | $534,000 | -25.2% | 40,013 | -15.7% | 0.00% | -33.3% |
| Q4 2016 | $714,000 | -99.9% | 47,459 | -1.0% | 0.00% | +50.0% |
| Q3 2016 | $560,185,000 | +7.9% | 47,920 | -0.3% | 0.00% | 0.0% |
| Q2 2016 | $519,124,000 | +21.6% | 48,067 | +3.9% | 0.00% | 0.0% |
| Q1 2016 | $427,000,000 | -34.9% | 46,243 | +4.6% | 0.00% | -33.3% |
| Q4 2015 | $656,000,000 | +91392.3% | 44,201 | +1.1% | 0.00% | 0.0% |
| Q3 2015 | $717,000 | -99.9% | 43,704 | -0.3% | 0.00% | -25.0% |
| Q2 2015 | $999,557,000 | +82.2% | 43,821 | +21.4% | 0.00% | +100.0% |
| Q1 2015 | $548,462,000 | +27.8% | 36,083 | +1.2% | 0.00% | 0.0% |
| Q4 2014 | $429,154,000 | +3.1% | 35,644 | -2.9% | 0.00% | 0.0% |
| Q3 2014 | $416,189,000 | -6.9% | 36,701 | -0.8% | 0.00% | 0.0% |
| Q2 2014 | $446,948,000 | +2.9% | 36,999 | -0.7% | 0.00% | 0.0% |
| Q1 2014 | $434,230,000 | -31.3% | 37,273 | +4.2% | 0.00% | -33.3% |
| Q4 2013 | $632,484,000 | +23.5% | 35,774 | +0.5% | 0.00% | 0.0% |
| Q3 2013 | $512,126,000 | -6.0% | 35,589 | -1.6% | 0.00% | 0.0% |
| Q2 2013 | $544,675,000 | – | 36,167 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,790,400 | $55,055,000 | 4.79% |
| Camber Capital Management LP | 3,250,000 | $64,123,000 | 3.26% |
| Avidity Partners Management LP | 200,000 | $3,946,000 | 2.49% |
| Asymmetry Capital Management, L.P. | 62,585 | $1,235,000 | 2.21% |
| Palo Alto Investors LP | 1,685,372 | $33,252,000 | 1.83% |
| Monashee Investment Management LLC | 90,223 | $1,780,000 | 1.66% |
| Greencape Capital Pty Ltd | 217,078 | $4,283,000 | 1.65% |
| Redmile Group, LLC | 3,237,700 | $63,880,000 | 1.53% |
| Ghost Tree Capital, LLC | 400,000 | $7,892,000 | 1.50% |
| Perceptive Advisors | 2,835,637 | $55,947,000 | 1.11% |